Post-acute sequelae of COVID-19 3 to 12 months after infection: Delta vs Omicron
In the first 9 months after infection, PASC prevalence was higher for Delta than Omicron, but the difference reduced over time and approximated after 12 months.
Authors
- Hans Knoop (ORCID: https://orcid.org/0000-0001-7763-3517)
- Hendriek C. Boshuizen (ORCID: https://orcid.org/0000-0002-3916-9095)
- Siméon de Bruijn (ORCID: https://orcid.org/0009-0000-6878-6298)
- Cees C. van den Wijngaard (ORCID: https://orcid.org/0000-0003-4309-0694)
- Elizabeth N. Mutubuki (ORCID: https://orcid.org/0000-0001-6471-1432)
- Tessa van der Maaden (ORCID: https://orcid.org/0000-0002-4029-6577)
- Eelco Franz (ORCID: https://orcid.org/0000-0003-3707-8648)
- Albert Jan van Hoek (ORCID: https://orcid.org/0000-0002-9244-0489)
- Anna D. Tulen
- Susan van den Hof
- Maarten Schipper (ORCID: https://orcid.org/0000-0001-6227-4603)
- Jeroen Rodenburg
Institutions
- National Institute for Public Health and the Environment (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1016/j.ijid.2024.107302
- Citations
- 5
- Primary Topic
- Dermatological and COVID-19 studies
- Type
- article
- Field-Weighted Citation Impact
- 2.67
Funders
- Ministerie van Volksgezondheid, Welzijn en Sport